Pub Date : 2020-02-01DOI: 10.20986/resed.2020.3747/2019
N. Esteve-Pérez, J. Iborra-Escalona, G. Gómez-Romero, C. Sansaloni-Perelló, A. M. Verger-Bennasar, S. Tejada-Gavela, M. Riera-Sagrera, L. C. Mora-Fernandez
{"title":"Efectividad de la analgesia controlada por el paciente en el dolor agudo y crónico de los pacientes después de cirugía cardiaca: estudio prospectivo","authors":"N. Esteve-Pérez, J. Iborra-Escalona, G. Gómez-Romero, C. Sansaloni-Perelló, A. M. Verger-Bennasar, S. Tejada-Gavela, M. Riera-Sagrera, L. C. Mora-Fernandez","doi":"10.20986/resed.2020.3747/2019","DOIUrl":"https://doi.org/10.20986/resed.2020.3747/2019","url":null,"abstract":"","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"24-36"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49099686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-02-01DOI: 10.20986/resed.2020.3717/2018
Anna Libran Oriol, Claudia Cruz-Sequeiros, Ana Luque-Blanco, Josep Porta-Sales
The opioid induced constipation (OIC) is an emerging clinical problems that worsen the patients’ quality of life requiring opioids for their pain relief. Many drugs have been launched as Peripheral Acting Mu Opioid Receptor Antagonists o PAMORAs (metylnaltrexone, alvimopam and more recently naloxegol), which antagonize the peripheral effects of opioids without affecting the opioids analgesia. Metylnaltrenone and naloxegol have been licensed for the treatment of CIO, meanwhile alvimopam is approved for the recovery of postoperative ileus after major abdominal surgery. All PAMORAs have shown clinical efficacy but is a matter of debate wich should be their role in the manangement of the CIO. The available information about PAMORAs is reviewed and informed strategy on the use of these drugs is proposed.
{"title":"Antagonistas periféricos de los receptores opioides Mu en el tratamiento del estreñimiento inducido por opioides: revisión.","authors":"Anna Libran Oriol, Claudia Cruz-Sequeiros, Ana Luque-Blanco, Josep Porta-Sales","doi":"10.20986/resed.2020.3717/2018","DOIUrl":"https://doi.org/10.20986/resed.2020.3717/2018","url":null,"abstract":"The opioid induced constipation (OIC) is an emerging clinical problems that worsen the patients’ quality of life requiring opioids for their pain relief. Many drugs have been launched as Peripheral Acting Mu Opioid Receptor Antagonists o PAMORAs (metylnaltrexone, alvimopam and more recently naloxegol), which antagonize the peripheral effects of opioids without affecting the opioids analgesia. Metylnaltrenone and naloxegol have been licensed for the treatment of CIO, meanwhile alvimopam is approved for the recovery of postoperative ileus after major abdominal surgery. All PAMORAs have shown clinical efficacy but is a matter of debate wich should be their role in the manangement of the CIO. The available information about PAMORAs is reviewed and informed strategy on the use of these drugs is proposed.","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"37-49"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68185637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-02-01DOI: 10.20986/resed.2020.3727/2019
J. C. Roche
{"title":"Eficacia de pregabalina, gabapentina y duloxentina en el dolor neuropático verificado por el por el análisis de la curva-p","authors":"J. C. Roche","doi":"10.20986/resed.2020.3727/2019","DOIUrl":"https://doi.org/10.20986/resed.2020.3727/2019","url":null,"abstract":"","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"16-23"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68185826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-02-01DOI: 10.20986/RESED.2020.3762/2019
José Miguel Esparza-Miñana, R. Vicedo-Lillo
Low back pain (LBP) is a common and important problem, with a high prevalence in women and the elderly. It is an important cause of pain, disability and economic detriment. In most cases, the pain is relieved in four to six weeks and people can return to normal activities. Acupuncture for the treatment of nonspecific low back pain remains a topic under investigation. We have carried out in this work a review of the most important articles published in the last 7 years (2013-2019), verifying the growth in the last years of alternative therapies. Acupuncture has demonstrated superiority in the improvement of non-specific low back pain when compared to the option of no treatment and, fundamentally, when it is associated with conventional treatment as a complement to it.
{"title":"Revisión del impacto del tratamiento con acupuntura en el manejo del dolor lumbar inespecífico","authors":"José Miguel Esparza-Miñana, R. Vicedo-Lillo","doi":"10.20986/RESED.2020.3762/2019","DOIUrl":"https://doi.org/10.20986/RESED.2020.3762/2019","url":null,"abstract":"Low back pain (LBP) is a common and important problem, with a high prevalence in women and the elderly. It is an important cause of pain, disability and economic detriment. In most cases, the pain is relieved in four to six weeks and people can return to normal activities. Acupuncture for the treatment of nonspecific low back pain remains a topic under investigation. We have carried out in this work a review of the most important articles published in the last 7 years (2013-2019), verifying the growth in the last years of alternative therapies. Acupuncture has demonstrated superiority in the improvement of non-specific low back pain when compared to the option of no treatment and, fundamentally, when it is associated with conventional treatment as a complement to it.","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"6 1","pages":"53-58"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68185934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.20986/resed.2020.3776/2019
C. E. V. Izquierdo, Marco Antonio Narváez Tamayo, Elena Sofía Renilla Carranza, Marco Fiestas Bancayan, Magel Rodríguez Calderón
{"title":"Bloqueo del plano del erector espinal como manejo de dolor neuropático en paciente pediátrico postquemado","authors":"C. E. V. Izquierdo, Marco Antonio Narváez Tamayo, Elena Sofía Renilla Carranza, Marco Fiestas Bancayan, Magel Rodríguez Calderón","doi":"10.20986/resed.2020.3776/2019","DOIUrl":"https://doi.org/10.20986/resed.2020.3776/2019","url":null,"abstract":"","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"127-132"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68185908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.20986/resed.2020.3775/2019
M. E. Fernández-Cuadros, O. Pérez-Moro, M. J. Albaladejo-Florín, S. Alava-Rabasa
{"title":"El ozono intraarticular modula la inflamación, mejora el dolor, la rigidez, la función y tiene un efecto anabólico sobre la artrosis de rodilla: estudio cuasi-experimental prospectivo tipo antes-después, 115 pacientes.","authors":"M. E. Fernández-Cuadros, O. Pérez-Moro, M. J. Albaladejo-Florín, S. Alava-Rabasa","doi":"10.20986/resed.2020.3775/2019","DOIUrl":"https://doi.org/10.20986/resed.2020.3775/2019","url":null,"abstract":"","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"78-88"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68186336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.20986/resed.2020.3759/2019
Carlos Alberto Lindado Pacheco, Santiago Gutiérrez, Sergio Ivan Patiño Ladino, Juan Carlos González
{"title":"Factores Biomecánicos Asociados al Resultado Clínico de Pacientes Tratados Con Artrodesis Lumbar en un Centro De Alta Complejidad en Colombia.","authors":"Carlos Alberto Lindado Pacheco, Santiago Gutiérrez, Sergio Ivan Patiño Ladino, Juan Carlos González","doi":"10.20986/resed.2020.3759/2019","DOIUrl":"https://doi.org/10.20986/resed.2020.3759/2019","url":null,"abstract":"","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68185912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.20986/resed.2020.3793/2020
D. González
Instrucciones de citación para el artículo / Citation instructions for the article: Abejón González David. Estimulación medular modulada automáticamente. Evidencia de los sistemas de estimulación cerrada: hacia el marcapasos del dolor / Spinal stimulation modulated automatically. Evidence of closed stimulation systems: towards the pain pacemaker. Rev. Soc. Esp. Dolor. 2020. doi: 10.20986/resed.2020.3793/2020.
{"title":"Estimulación medular modulada automáticamente. Evidencia de los sistemas de estimulación cerrada: hacia el marcapasos del dolor","authors":"D. González","doi":"10.20986/resed.2020.3793/2020","DOIUrl":"https://doi.org/10.20986/resed.2020.3793/2020","url":null,"abstract":"Instrucciones de citación para el artículo / Citation instructions for the article: Abejón González David. Estimulación medular modulada automáticamente. Evidencia de los sistemas de estimulación cerrada: hacia el marcapasos del dolor / Spinal stimulation modulated automatically. Evidence of closed stimulation systems: towards the pain pacemaker. Rev. Soc. Esp. Dolor. 2020. doi: 10.20986/resed.2020.3793/2020.","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"5-6"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68186823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.20986/resed.2020.3814/2020
Borja Mugabure Bujedo, S. G. Santos, A. U. Azpiazu, Antía Osorio López
Patients with sickle cell disease (SCD) suffer from severe pain that often begins in childhood and increases in severity over the course of a lifetime, leading to hospitalization and poor quality of life over the years. A unique feature of SCD is vaseocclusive crises (VOC) characterized by recurrent and unpredictable episodes of acute pain. Microvascular occlusion during a VOC results in decreased oxygen supply to the periphery and injury from ischemia and subsequent reperfusion, inflammation, oxidative stress and endothelial dysfunction, all of which can perpetuate a harmful paincausing microenvironment. On the other hand, in addition to episodic acute pain, SCD patients also report chronic pain, defined as almost daily pain over a 6-month period associated to either sicologic or social morbidities. They may be due to chronic lesions such as skin ulcers, avascular bone necrosis or infarctions in various organs. In addition, central sensitization appears to be directly involved in the chronicity of pain and there
{"title":"Fisiopatología clínica en pacientes con enfermedad de células falciformes: la transición del dolor agudo al crónico","authors":"Borja Mugabure Bujedo, S. G. Santos, A. U. Azpiazu, Antía Osorio López","doi":"10.20986/resed.2020.3814/2020","DOIUrl":"https://doi.org/10.20986/resed.2020.3814/2020","url":null,"abstract":"Patients with sickle cell disease (SCD) suffer from severe pain that often begins in childhood and increases in severity over the course of a lifetime, leading to hospitalization and poor quality of life over the years. A unique feature of SCD is vaseocclusive crises (VOC) characterized by recurrent and unpredictable episodes of acute pain. Microvascular occlusion during a VOC results in decreased oxygen supply to the periphery and injury from ischemia and subsequent reperfusion, inflammation, oxidative stress and endothelial dysfunction, all of which can perpetuate a harmful paincausing microenvironment. On the other hand, in addition to episodic acute pain, SCD patients also report chronic pain, defined as almost daily pain over a 6-month period associated to either sicologic or social morbidities. They may be due to chronic lesions such as skin ulcers, avascular bone necrosis or infarctions in various organs. In addition, central sensitization appears to be directly involved in the chronicity of pain and there","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.20986/resed.2020.3744/2019
M. T. V. Herrero, M. V. R. L. Torre, L. Barbero, Elena Ruiz de la Torre
Goals: To know the use of migraine crisis symptomatic treatments in different countries of Europe and the differences observed depending on social and demographic variables. Material and methods: Cross-sectional observational study by anonymous web survey to 3,342 patients from Spain, Italy, France, Portugal, Ireland, United Kingdom, Germany and other countries of the European Union. Study variables: age, gender, country, type of location, level of studies and rural or urban area. The symptomatic treatments that are collected are: simple analgesics, non-steroidal anti-inflammatory drugs, triptans, other treatments, several treatments, without treatment, ignorance of symptomatic treatment. Results: For simple analgesics, the largest consumers are between 41-60 years (p < 0.0001). Spain and Germany are the countries with the highest use (p < 0.0001). For the anti-inflammatories, the greatest use is between 21-60 years (p < 0.0001). Spain, Italy and Germany are the countries that make the most use of them (p < 0.0001) and higher consumption in patients with higher education (p < 0.003). Triptans use shows a relationship with age and gender, greater use between 21-60 years (p < 0.0001) and in women (p < 0.0001). By countries, the highest consumption is in Germany, the rest of the European Union countries, Spain and the United Kingdom (p < 0.0001). Greater consumption in patients living in cities with more than 500 inhabitants (p < 0.010) and with medium or higher studies (p < 0.0001). In the group of middle and upper studies, we find, by contrast, the highest percentage of patients who do not know what a symptomatic treatment is (p < 0.0001). Conclusions: The result varies according each country greatly and they are modified depending on different social and demographic conditions, being the age, gender, rural or urban environment and cultural level the factors that most affect the use of each symptomatic medication for the migraine crisis.
{"title":"Tratamiento sintomático en migraña. Fármacos utilizados y variables relacionadas. Resultados de la encuesta europea Trabajo y Migraña","authors":"M. T. V. Herrero, M. V. R. L. Torre, L. Barbero, Elena Ruiz de la Torre","doi":"10.20986/resed.2020.3744/2019","DOIUrl":"https://doi.org/10.20986/resed.2020.3744/2019","url":null,"abstract":"Goals: To know the use of migraine crisis symptomatic treatments in different countries of Europe and the differences observed depending on social and demographic variables. Material and methods: Cross-sectional observational study by anonymous web survey to 3,342 patients from Spain, Italy, France, Portugal, Ireland, United Kingdom, Germany and other countries of the European Union. Study variables: age, gender, country, type of location, level of studies and rural or urban area. The symptomatic treatments that are collected are: simple analgesics, non-steroidal anti-inflammatory drugs, triptans, other treatments, several treatments, without treatment, ignorance of symptomatic treatment. Results: For simple analgesics, the largest consumers are between 41-60 years (p < 0.0001). Spain and Germany are the countries with the highest use (p < 0.0001). For the anti-inflammatories, the greatest use is between 21-60 years (p < 0.0001). Spain, Italy and Germany are the countries that make the most use of them (p < 0.0001) and higher consumption in patients with higher education (p < 0.003). Triptans use shows a relationship with age and gender, greater use between 21-60 years (p < 0.0001) and in women (p < 0.0001). By countries, the highest consumption is in Germany, the rest of the European Union countries, Spain and the United Kingdom (p < 0.0001). Greater consumption in patients living in cities with more than 500 inhabitants (p < 0.010) and with medium or higher studies (p < 0.0001). In the group of middle and upper studies, we find, by contrast, the highest percentage of patients who do not know what a symptomatic treatment is (p < 0.0001). Conclusions: The result varies according each country greatly and they are modified depending on different social and demographic conditions, being the age, gender, rural or urban environment and cultural level the factors that most affect the use of each symptomatic medication for the migraine crisis.","PeriodicalId":35974,"journal":{"name":"Revista de la Sociedad Espanola del Dolor","volume":"27 1","pages":"178-191"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68185480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：